BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 13, 2007
View Archived Issues
Recent patents disclose novel therapeutic agents for cardiovascular disorders
Read More
Novel estrone sulfatase inhibitor may be useful in ovarian cancer therapy
Read More
DDP-733 reduces esophageal reflux
Read More
Dimebon's benefits in Alzheimer's continue at 12 months
Read More
Nimotuzumab cleared for phase II trials in Canada for pediatric brain cancer and colorectal cancer
Read More
Cortex extends Ampakine license agreement with University of California, Irvine
Read More
Tanabe Seiyaku reports proof of concept for SGLT-2 inhibitor
Read More
Boston Life Sciences changes name to Alseres Pharmaceuticals
Read More
Novel gene therapy approach restores cone photoreceptor function in mouse models of cone dystrophies
Read More
New telomerase-targeting adenovirus therapy proves safe in preclinical studies
Read More
Innocoll files IND for surgical implant
Read More
Health Canada approves expanded indication for Plavix
Read More
Phase I results reported for dual Met/VEGFR-2 inhibitor XL-880
Read More
SBG enters phase III for diabetic ulcers
Read More
ARC-1779 completes phase I study
Read More
KB-2115 completes proof-of-concept phase II study in dyslipidemia
Read More
FDA requests additional data on alvimopan for postoperative ileus
Read More
Neopharm signs license for cintredekin besudotox in pulmonary fibrosis, asthma
Read More
Archemix signs aptamer agreements
Read More
CE Mark for OraQuick Advance Rapid HIV-1/2 Antibody Test
Read More
New phase I study of VB6-845 in advanced epithelial cancers
Read More
Preliminary clinical data on OGX-011 in prostate, non-small cell lung cancer presented
Read More
Apomab, a DR5 agonist antibody, well tolerated in initial clinical evaluation
Read More
Optaflu approved in E.U.
Read More
Pro-Pharmaceuticals begins filing for Davanat in coadministration with irinotecan
Read More
Favorable safety data reported for Stimuvax vaccine
Read More
AZD-0530 inhibits Src activity in human cancers
Read More
The anti-TGF-beta2 inhibitor AP-12009 in patients with solid tumors and tumors of the CNS
Read More
Japanese launch for Myozyme
Read More
New agents for treating neurological disorders disclosed in recent patent literature
Read More